EZH2 and breast carcinoma: We also demonstrated that tumor-associated maceophages (TAMs) facilitate PRMT1-mediated R342-EZH2 ADMA methylation by secreting IL-6, which strengthens EZH2 protein stability and enhances breast cancer cells motility [75].